A new era in rehabilitative care is dawning with the strategic combination of Hanger Inc., a leader in orthotic and prosthetic (O&P) patient care, and Numotion, a dominant provider of complex rehabilitation technology (CRT) and mobility solutions. This monumental merger, set to culminate in the fourth quarter of 2026, will create a unified entity operating under the name Hanger Numotion, poised to serve over 1.5 million patients annually across North America. The deal, structured as an acquisition of Numotion by Hanger, will establish a comprehensive platform offering an unparalleled spectrum of mobility and independence solutions, signaling a significant shift in the post-acute care landscape.
Main Facts: Uniting Giants for Integrated Care
The healthcare industry is witnessing a transformative consolidation as Hanger Inc., a long-standing pioneer in orthotics and prosthetics, moves to acquire Numotion, a preeminent force in complex rehabilitation technology and mobility products. This strategic alliance is designed to create Hanger Numotion, a scaled North American platform with complementary capabilities spanning the critical domains of O&P, CRT, and a broader range of mobility and independence solutions. The combined entity will represent an formidable network, leveraging Hanger’s extensive footprint of 925 U.S.-based O&P clinics and Numotion’s robust presence across more than 200 locations throughout the U.S. and Canada.
This ambitious merger is not merely an aggregation of assets but a deliberate move to enhance patient care and expand access to vital services. The unified organization is projected to serve a staggering 1.5 million patients annually, offering a more integrated and holistic approach to rehabilitation and long-term mobility support. The transaction, structured as a cash acquisition of Numotion by Hanger, will result in Patient Square Capital assuming control of the newly formed company. Numotion, previously a portfolio company of AEA Investors (AEA), brings its established expertise and market leadership in CRT, which includes custom power wheelchairs, manual wheelchairs, adaptive seating, and other specialized mobility equipment. Hanger, with its deep roots and extensive clinical experience in designing, fitting, and fabricating custom orthotic and prosthetic devices, complements Numotion’s offerings perfectly.
A pivotal aspect of this merger involves the leadership transition. Mike Swinford, the highly respected CEO of Numotion since 2014, is slated to assume the helm of the combined Hanger Numotion upon the transaction’s close. Swinford’s proven track record in scaling businesses and his extensive experience, including a significant tenure as President and CEO of GE Healthcare Services, underscore the strategic intent to drive sustained growth and innovation. Pete Stoy, the current CEO of Hanger Inc., will transition from his role, expressing immense pride in Hanger’s transformation under his leadership and confidence in Swinford’s capacity to guide the new entity forward. Both companies will continue to operate under their existing brands and maintain their respective clinical operations post-acquisition, ensuring continuity and stability for patients and staff alike as the integration process unfolds towards the anticipated close in late 2026.
Chronology: A Strategic Convergence in Healthcare
The journey towards the formation of Hanger Numotion is rooted in the distinct yet parallel evolutions of two industry leaders and the broader trends shaping the rehabilitative healthcare sector. While the specific timeline of the merger discussions remains private, the announcement signifies the culmination of a strategic process likely initiated well in advance of the public disclosure.
Hanger’s Legacy and Recent Trajectory: Hanger Inc. boasts a rich history, tracing its origins back to the American Civil War when its founder, James Edward Hanger, developed the first articulated prosthetic limb. For over a century, Hanger has remained at the forefront of O&P innovation, evolving into the largest provider of O&P patient care services in the U.S. In recent years, under the leadership of Pete Stoy, Hanger has focused on solidifying its national platform, investing in its clinical talent, technology, and operational capabilities to meet the growing demands of its patient base. This period saw Hanger strengthening its integrated approach to O&P care, emphasizing personalized solutions and evidence-based practices.
Numotion’s Ascent and Growth under AEA Investors: Numotion, on the other hand, emerged as a dominant force in the complex rehabilitation technology (CRT) and mobility sector. As a portfolio company of AEA Investors, Numotion experienced significant growth and expansion, particularly under the stewardship of Mike Swinford since 2014. Swinford successfully diversified Numotion’s offerings and scaled its operations, cementing its position as a leading provider of essential mobility products and services across North America. This growth trajectory was driven by strategic acquisitions, organic expansion, and a relentless focus on serving individuals with complex mobility needs.
The Genesis of the Merger: The impetus for combining these two powerhouses likely stemmed from a recognition of the increasing overlap in patient needs and the benefits of offering a more unified care pathway. Patients often require both O&P services (e.g., custom prosthetics after an amputation) and CRT solutions (e.g., a specialized power wheelchair for mobility). Historically, these services have been provided by separate entities, necessitating coordination challenges for patients, caregivers, and referring physicians. The vision of an integrated platform, offering seamless transitions and coordinated care, became a compelling strategic imperative. Patient Square Capital, a prominent healthcare-focused private equity firm, played a crucial role in orchestrating and facilitating this strategic combination, aligning the interests of both companies and providing the capital structure for the acquisition. Their investment philosophy centers on building market-leading healthcare companies that can drive innovation and improve patient outcomes.
The Announcement and Future Outlook: The formal announcement of the acquisition signifies a major milestone. The transaction’s structure as a cash acquisition of Numotion by Hanger underscores the financial engineering involved in bringing these entities together under the control of Patient Square Capital. The anticipated closing date in the fourth quarter of 2026 is notable. Such a long lead time is common in complex, large-scale mergers within the healthcare sector, often necessitated by rigorous regulatory reviews, including antitrust considerations, and the intricate process of financial structuring and operational integration planning. This extended period allows for meticulous preparation, ensuring a smooth transition for patients, employees, and stakeholders while addressing the multifaceted challenges of combining two large, geographically dispersed organizations with distinct operational models and cultures. The phased approach is designed to minimize disruption and maximize the realization of synergies post-close.
Supporting Data: Market Dynamics and Strategic Rationale
The formation of Hanger Numotion is not merely a corporate transaction; it’s a response to evolving market dynamics and a strategic bet on the future of rehabilitative healthcare. Several key factors underpin the rationale for this unprecedented merger, highlighting the significant growth potential and synergistic benefits.
Expanding Market Opportunity:
The orthotics and prosthetics (O&P) market and the complex rehabilitation technology (CRT) market are both experiencing robust growth, driven by an aging global population, increasing prevalence of chronic diseases, traumatic injuries, and advancements in medical technology.
- O&P Market: Estimates suggest the global O&P market is valued at tens of billions of dollars and is projected to grow at a compound annual growth rate (CAGR) of 5-7% over the next decade. Drivers include increased rates of diabetes-related amputations, sports injuries, and musculoskeletal conditions requiring orthotic intervention. Innovations in materials (e.g., carbon fiber, smart polymers), 3D printing, and microprocessor-controlled prosthetics are continually expanding treatment options and improving patient outcomes.
- CRT Market: The CRT market, encompassing highly specialized wheelchairs, seating systems, and other mobility devices, is also a multi-billion-dollar industry with similar growth projections. The demand is fueled by conditions such as spinal cord injuries, cerebral palsy, multiple sclerosis, and amyotrophic lateral sclerosis (ALS), which necessitate custom-configured equipment for mobility, posture management, and independence. The complexity of these devices requires specialized clinical assessment, fitting, and ongoing support, distinguishing CRT from standard durable medical equipment.
Synergies and Value Proposition:
The combination of Hanger and Numotion creates a powerful synergy that extends beyond simple market share aggregation. It addresses critical gaps in the continuum of care and unlocks significant opportunities for enhanced value creation.
- Expanded Patient Access and Integrated Care Pathways: The most compelling synergy lies in the ability to offer a truly integrated patient journey. Patients requiring a prosthetic limb may also need a specialized wheelchair for non-ambulatory periods or specific adaptive equipment for home modifications. By bringing O&P and CRT under one umbrella, Hanger Numotion can provide coordinated assessments, device provision, and follow-up care. This reduces fragmentation, simplifies the patient experience, and ensures more holistic and effective rehabilitation plans. With over 1,100 combined locations across North America, the geographic reach will significantly expand access to specialized care, particularly in underserved regions.
- Operational Efficiencies and Scale: A combined entity of this magnitude will benefit from considerable operational efficiencies. Scale advantages can be realized in purchasing power for components, materials, and administrative services. Centralized functions such as billing, IT infrastructure, human resources, and supply chain management can lead to cost savings and improved service delivery. Furthermore, a larger organization can invest more effectively in robust data analytics, allowing for better tracking of patient outcomes, operational performance, and market trends.
- Investment in Innovation and R&D: The combined financial strength and expertise of Hanger Numotion will provide greater resources for research and development. This can accelerate the adoption of new technologies in both O&P and CRT, from advanced sensor-integrated prosthetics and robotic exoskeletons to intelligent power wheelchair systems and personalized adaptive seating solutions. Investing in clinical research will also allow the company to contribute to evidence-based practices, further solidifying its leadership position and improving patient outcomes.
- Talent Attraction, Development, and Retention: In a highly specialized field, attracting and retaining top clinical talent is paramount. A larger, more diversified company like Hanger Numotion can offer expanded career development opportunities for orthotists, prosthetists, rehabilitation technology suppliers (RTS), and technicians. Cross-training initiatives, shared best practices, and a broader scope of patient conditions can enrich professional experiences, fostering a highly skilled and engaged workforce. The ability to offer a comprehensive range of services also makes the organization a more attractive employer for clinicians seeking diverse challenges and a greater impact on patient lives.
- Advocacy and Policy Influence: A combined entity of this scale will have a more significant voice in advocating for patient access, fair reimbursement policies, and beneficial legislative changes within the complex healthcare regulatory environment. This influence can help shape policies that support innovation, ensure adequate coverage for O&P and CRT services, and ultimately benefit the broader patient community.
Financial Underpinnings: While specific financial terms were not disclosed, the "cash acquisition" structure indicates a significant capital deployment, likely backed by Patient Square Capital’s substantial resources. Private equity firms like Patient Square Capital are increasingly drawn to healthcare services due to their defensive characteristics, stable demand, and opportunities for operational improvement and strategic consolidation. Their long-term investment horizon aligns with the vision of building a market-leading platform designed for sustainable growth and value creation. The transaction’s projected close in late 2026 suggests a complex financial and legal structuring, emphasizing the magnitude and strategic importance of this merger to all parties involved.
Official Responses: A Shared Vision for Mobility
The announcement of the Hanger and Numotion merger has been met with enthusiastic affirmations from the key leaders involved, underscoring a shared philosophy centered on patient well-being, innovation, and expanding access to critical mobility solutions. Their public statements reflect not just the strategic rationale but also a deep personal commitment to the mission of empowering individuals through enhanced mobility and independence.
Mike Swinford, Incoming CEO of Hanger Numotion:
As the designated leader of the combined entity, Mike Swinford articulated a clear vision for the future, emphasizing the foundational belief shared by both organizations. "Our two companies share a fundamental belief in the role mobility can play in improving people’s lives," Swinford stated. This sentiment is central to the merger’s promise, highlighting that the combination is driven by a common purpose beyond mere business expansion. He continued, "By bringing together our respective experience, capabilities, and passion to serve our customers and patients, we have an opportunity to build on each company’s strengths and help more people across their mobility journeys." This statement not only acknowledges the distinct expertise each company brings to the table – Hanger’s O&P prowess and Numotion’s CRT leadership – but also points to the transformative potential of their integration.
Swinford’s tenure at Numotion since 2014 has been marked by strategic growth, diversification, and a steadfast commitment to patient-centric care, positioning the company as a mobility leader. His prior experience as President and CEO of GE Healthcare Services further burnishes his credentials for leading a large, complex healthcare organization. In his remarks, he also extended gratitude to Numotion’s past partners, stating, "I’d like to personally thank Pete for his outstanding leadership, AEA for its strong partnership and commitment as Numotion’s primary investor, and LLR for its longstanding investment in and support of the company." This acknowledgment reflects a collaborative spirit and an appreciation for the journey that has led to this significant milestone. Looking forward, Swinford expressed excitement about working with teams across Hanger, Numotion, and Patient Square, reaffirming their collective commitment to "helping people live with greater mobility and independence." His vision is clearly one of seamless integration, leveraging combined strengths to achieve a greater impact on patient lives.
Pete Stoy, Current CEO of Hanger Inc.:
Pete Stoy, who has successfully steered Hanger through a period of significant transformation since joining in 2020, conveyed immense pride in his team’s accomplishments and expressed strong confidence in the future under new leadership. "I am incredibly proud of what our team has accomplished at Hanger and the transformation the business has undergone since I joined the company in 2020," Stoy remarked. He highlighted key achievements during his tenure, including the development of "a stronger, more integrated national platform," significant investments in "our people, technology, and capabilities," and positioning Hanger for "sustained growth." These efforts have laid a robust foundation for the company’s next chapter.
Stoy’s endorsement of Mike Swinford is particularly significant, signaling a smooth leadership transition. "I have worked with Mike closely throughout this process, and I have tremendous confidence in his ability to lead Hanger Numotion following the close of the transaction," he affirmed. This close collaboration during the merger process suggests a thoughtful and deliberate handover of responsibilities. Stoy further praised Swinford as "an accomplished leader who shares our commitment to patients and our people," emphasizing the continuity of values and mission. He concluded by expressing his belief that Swinford is "well-positioned to build on Hanger’s momentum and realize the tremendous potential of the combined organization ahead," reinforcing the idea that this merger is an evolutionary step, building on existing strengths to unlock new possibilities.
Patient Square Capital’s Strategic Intent (Inferred):
As the controlling entity, Patient Square Capital’s implicit response is one of strategic foresight and a commitment to investing in transformative healthcare platforms. Their involvement signifies a belief in the long-term value creation potential of combining these two market leaders. Patient Square Capital’s investment philosophy typically focuses on companies that are poised to address significant unmet healthcare needs, leverage technological advancements, and deliver superior patient outcomes. By backing Hanger Numotion, they are signaling their confidence in the ability of this integrated platform to become a dominant force in the post-acute rehabilitative care market, driving innovation, efficiency, and expanded access to care across North America. Their role is not just financial, but strategic, guiding the combined entity towards realizing its full potential as a leader in mobility solutions.
Implications: A New Paradigm for Mobility and Independence
The merger of Hanger and Numotion is poised to send ripples across the rehabilitative healthcare landscape, with far-reaching implications for patients, employees, competitors, and the broader industry. This consolidation is not merely about creating a larger company; it’s about reshaping the delivery of mobility and independence solutions.
For Patients:
The most significant implication for patients is the potential for a more streamlined, integrated, and comprehensive care experience.
- Holistic Care: Patients who require both O&P and CRT services, such as individuals with limb loss needing prosthetics and specialized wheelchairs, will theoretically benefit from a single point of contact and coordinated care plans. This could reduce the burden of navigating multiple providers and improve communication among clinical teams.
- Expanded Access: With a combined network exceeding 1,100 locations across the U.S. and Canada, geographic access to specialized services may improve, especially in areas where one service might have been less readily available.
- Innovation: Greater resources for research and development within the combined entity could translate into faster adoption of cutting-edge technologies and therapies, offering patients access to the most advanced prosthetic devices, orthotic solutions, and complex rehabilitation equipment.
- Potential Challenges: While the vision is positive, the integration of two large companies can present temporary challenges. Patients might experience initial administrative adjustments or changes in service delivery models during the transition period. Ensuring that the high standards of personalized care are maintained across all locations will be crucial.
For Employees and Clinicians:
The merger brings both opportunities and potential challenges for the dedicated professionals who are the backbone of both Hanger and Numotion.
- Enhanced Professional Development: Clinicians (orthotists, prosthetists, rehabilitation technology suppliers, physical therapists, occupational therapists) may find expanded opportunities for cross-training, skill diversification, and professional growth within a larger, more diversified organization.
- Career Pathways: A larger company can offer more varied career paths, leadership roles, and opportunities to specialize or contribute to broader organizational initiatives like clinical research or product development.
- Shared Best Practices: The integration of clinical knowledge and operational expertise from both O&P and CRT sectors can lead to the development of new best practices, improving the quality and consistency of care.
- Cultural Integration: The primary challenge will be integrating two distinct corporate cultures. Ensuring that employees feel valued, that their expertise is respected, and that the transition is managed transparently will be vital for maintaining morale and productivity. While clinical operations will remain separate, administrative and support functions will undergo significant integration.
For Competitors:
The formation of Hanger Numotion immediately establishes a formidable market leader, setting a new benchmark for scale and integrated service delivery.
- Increased Competition: Smaller, regional O&P and CRT providers may face intensified competition from a larger, more resource-rich entity. This could spur further consolidation within these fragmented markets as smaller players seek to gain scale or specialize to compete effectively.
- Pressure to Innovate: Competitors may be compelled to accelerate their own innovation efforts and explore partnerships or acquisitions to offer more comprehensive solutions to patients.
- Market Dynamics: The merger could shift the competitive landscape, potentially influencing pricing strategies, service offerings, and market positioning across the industry.
For the Healthcare Industry and Payers:
This merger represents a significant trend in healthcare towards consolidation and the creation of integrated platforms designed to improve efficiency and outcomes.
- Value-Based Care Model: The combined entity is well-positioned to demonstrate the value of integrated O&P and CRT services in a value-based care environment, potentially leading to better patient outcomes and reduced long-term healthcare costs.
- Influence on Reimbursement: As a larger player, Hanger Numotion will likely have a more significant voice in discussions with government agencies and private payers regarding reimbursement policies for O&P and CRT, advocating for appropriate coverage and fair compensation for complex, highly individualized services.
- Data and Analytics: The scale of the combined company will generate vast amounts of patient data, which, if leveraged responsibly, could provide invaluable insights into patient outcomes, treatment efficacy, and opportunities for continuous improvement in care delivery.
For Investors:
The transaction underscores private equity’s continued strong interest in the healthcare services sector, particularly in areas with stable demand and growth potential.
- Long-Term Value Creation: Patient Square Capital’s investment signals a belief in the long-term value creation potential through market leadership, operational synergies, and innovation. The extended closing timeline suggests a methodical approach to maximizing this value.
- Industry Benchmark: The success of Hanger Numotion will serve as an important case study for future strategic mergers and acquisitions in specialized healthcare segments, influencing investment decisions and market strategies.
In conclusion, the Hanger Numotion merger is more than a corporate event; it’s a strategic realignment of significant forces within rehabilitative healthcare. It promises to create a more integrated, efficient, and innovative ecosystem for individuals seeking mobility and independence solutions, potentially setting a new standard for patient care in North America. The journey to the 2026 close will be closely watched, as the industry anticipates the unveiling of this new paradigm in comprehensive mobility services.
